Yerevan State Medical University, Armenia Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2018
NCT03479983
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Yerevan State Medical University | Yerevan State Medical University, Armenia

Active Ingredients

Drugs in Phase 4 Trials (3)

amlodipine (norvasc) (1 trial)

atorvastatin (lipitor) (1 trial)

perindopril (aceon) (1 trial)

Drugs in Other Trials (1)

phyllanthus (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Essential Hypertension (Phase 4)

Hypercholesterolemia (Phase 4)

Hypertension (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4